A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating

Recruiting

FODZYME®A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating

Sponsor:

Kiwi Health Inc

Code:

NCT07591584

Conditions

IBS (Irritable Bowel Syndrome)

Bloating

Abdominal Pain

Gut Health

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

FODMAP-targeting digestive enzyme blend

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-25. This information was provided to ClinicalTrials.gov by Kiwi Health Inc on 2026-05-15.